Literature DB >> 913894

Diminution of bone mass in childhood diabetes.

A L Rosenbloom, D C Lezotte, F T Weber, J Gudat, D R Heller, M L Weber, S Klein, B B Kennedy.   

Abstract

Photon absorption measurements of forearm bone density in 196 insulin-dependent patients, age 6--26 years, were compared with findings in 124 controls. Expected density, gm. Ca/cm.2 bone width (M/W), was calculated from regressions of M/W on ulnar length for white and black male and female controls. There were no significant correlations between M/W differences from expected and serum Ca, Mg, P, or alkaline phosphatase levels, estimated physical activity level, insulin dosage, or the presence of joint contracture. White females averaged 8.2 per cent (+/- 1 S.E.M.) loss of M/W, as against white male average loss of 4.7 per cent +/- 1 and black female loss of 2 per cent +/- 2 (p less than 0.001); the black male population was too small for separate analysis. M/W loss greater than 10 per cent was seen in 29 per cent of white males, 19 per cent of blacks, and 48 per cent of white females (p less than 0.02). When the groups were further divided into those with duration of diabetes less than or equal to five years and those with duration greater than five years, significant reduction in M/W average loss over time was seen with white females (10.6 per cent +/- 1.2 to 3.7 per cent+/- 1.5, p less than 0.0001). Expression of this defect in bone mineralization is controlled by race and sex acting independently of each other.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913894     DOI: 10.2337/diab.26.11.1052

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

1.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

2.  Effects of advanced glycation end-products on the proliferation and differentiation of osteoblast-like cells.

Authors:  A D McCarthy; S B Etcheverry; L Bruzzone; A M Cortizo
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

3.  Intestinal calcium absorption during hyperinsulinemic euglycemic glucose clamp in healthy humans.

Authors:  G Rümenapf; J Schmidtler; P O Schwille
Journal:  Calcif Tissue Int       Date:  1990-02       Impact factor: 4.333

Review 4.  Skeletal growth and bone mineral acquisition in type 1 diabetic children; abnormalities of the GH/IGF-1 axis.

Authors:  Manish Raisingani; Brar Preneet; Brenda Kohn; Shoshana Yakar
Journal:  Growth Horm IGF Res       Date:  2017-04-28       Impact factor: 2.372

Review 5.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

6.  Bone mass in obese, goldthioglucose-treated, hyperglycaemic mice.

Authors:  I De Leeuw; P Van Rooy; M D'Hollander
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

7.  Evaluation of bone mineral density in children with diabetes mellitus.

Authors:  B Ersoy; D Gökşen; S Darcan; E Mavi; C Oztürk
Journal:  Indian J Pediatr       Date:  1999 May-Jun       Impact factor: 1.967

Review 8.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

9.  Osteodystrophy of diabetics in chronic dialysis: a histomorphometric study.

Authors:  J Aubia; S Serrano; L Mariñoso; L Hojman; A Diez; J Lloveras; J Masramon
Journal:  Calcif Tissue Int       Date:  1988-05       Impact factor: 4.333

10.  Osteopenia in juvenile diabetes.

Authors:  R M Shore; R W Chesney; R B Mazess; P G Rose; G J Bargman
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.